Pegaptanib (sodium)
Pegaptanib sodium is an RNA aptamer with polyethylene glycol modifications, which is directed against vascular endothelial growth factor (VEGF) -165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD) [1].
Product Specifications
CAS Number
222716-86-1
Product Name Alternative
EYE001; NX1838
UNSPSC
12352208
Target
VEGFR
Type
Oligonucleotides
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Inflammation/Immunology; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pegaptanib-sodium.html
Purity
90.51
Solubility
H2O : 10 mg/mL (ultrasonic)
Smiles
[Pegaptanib(sodium)]
Molecular Formula
C294H342F13N107Na28O188P28[C2H4O]n
Molecular Weight
50000 (Approximately)
References & Citations
[1]Eugene W M Ng, et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov. 2006 Feb;5 (2) :123-32.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CF®505 Donkey Anti-Goat IgG (H+L), Highly Cross-Adsorbed, single label for STORM, 1 mg/mL
Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin
